Investigating how a virus affects cancer cell behavior and treatment options
PARP1-Chromatin and NAD-Metabolism in EBV Epithelial Cancers
This study is looking at how the Epstein-Barr Virus affects certain types of cancer and how a protein called PARP1 might help us find better treatments for patients with these cancers.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11085163 on NIH RePORTER |
What this research studies
This research focuses on understanding how Epstein-Barr Virus (EBV) influences the development and treatment of certain epithelial cancers. The team is exploring the role of a protein called PARP1 in regulating the virus's activity and its impact on cancer cell metabolism. By studying how PARP1 interacts with the EBV genome and affects gene expression, the researchers aim to identify new therapeutic strategies that could specifically target EBV-related tumors. This could lead to more effective treatments tailored for patients with these cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with EBV-positive epithelial cancers, such as gastric cancer.
Not a fit: Patients with EBV-negative cancers or those without epithelial cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted therapies for patients with EBV-related epithelial cancers.
How similar studies have performed: Previous research has shown promising results in targeting PARP proteins in cancer treatment, indicating potential success for this approach.
Where this research is happening
Philadelphia, United States
- Wistar Institute — Philadelphia, United States (Active)
Researchers
- Principal investigator: Tempera, Italo — Wistar Institute
- Study coordinator: Tempera, Italo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.